Reduced CD109 expression on tumor-associated endothelial cells (TEC) is linked to advanced tumor features, including larger size, microvascular invasion, and increased tumor progression, proliferation, migration, and hepatoma cell invasion via enhanced IL-8 secretion. This evidence concerns the gene CD109 and hepatocellular carcinoma.